Top Markets
Coin of the day
Atrion Corporation Atrion Corporation

Atrion Corporation

ATRI
Rank in Stocks #38752
Atrion Corporation, along with its affiliated entities, specializes in the... Atrion Corporation, along with its affiliated entities, specializes in the development, production, and global distribution of medical devices for fluid management, cardiovascular health, and ophthalmology, reaching markets across the United States, Canada, Europe, and beyond. Its fluid management portfolio includes valves designed to precisely regulate the flow of liquids or gases, vital for various intubation, intravenous, and catheter applications in anesthesia and oncology, and instrumental in promoting infection control in both hospital and home healthcare environments. In the cardiovascular segment, the company offers a Myocardial Protection System that delivers essential fluids and medications, accurately mixes critical drugs, and meticulously controls variables such as temperature and pressure. This division also provides vacuum relief valves for cardiac surgeries, silicone vessel loops used for retracting and occluding blood vessels, and inflation devices crucial for balloon catheter expansion, stent placement, and fluid delivery, along with other products for heart bypass procedures. For ophthalmology, Atrion supplies specialized medical apparatus for sterilizing contact lenses and a range of balloon catheters employed to treat nasolacrimal duct obstructions in pediatric and adult patients. Beyond these core areas, the corporation also manufactures instruments and corresponding single-use items for assessing the activated clotting time of blood, and secure containment solutions for needles and scalpel blades. Furthermore, Atrion fabricates inflation mechanisms and valves for maritime and aerospace safety equipment, essential components for inflatable survival gear and structures, and both unidirectional and bidirectional pressure relief valves. These valves are crucial for safeguarding delicate electronics and various other goods during transit, serving both medical and non-medical contexts. Atrion distributes its comprehensive suite of products to a diverse client base, including medical practitioners, hospitals, clinics, other care facilities, and fellow equipment manufacturers. This distribution is managed through a multi-channel approach, utilizing a dedicated direct sales team, independent representatives, and a broad network of distributors. Established in 1944, Atrion Corporation maintains its primary operational base in Allen, Texas.
Share Price
$0.45992
Last synced: 2024-08-30
Market Cap
$821.42K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Atrion Corporation (ATRI)

Category

P/E ratio for Atrion Corporation (ATRI)
P/E ratio as of August 2026 TTM: 41.74
According to Atrion Corporation latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 41.74. At the end of 2022 the company had a P/E ratio of 28.56.
P/E ratio history for Atrion Corporation from 2000 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) 41.74 21.46%
2023 34.36 20.33%
2022 28.56 -26.18%
2021 38.68 5.36%
2020 36.72 -3.18%
2019 37.92 -5.40%
2018 40.09 26.02%
2017 31.81 -5.16%
2016 33.54 37.87%
2015 24.33 1.62%
2014 23.94 6.87%
2013 22.40 33.96%
2012 16.72 -10.23%
2011 18.63 7.77%
2010 17.28 -5.53%
2009 18.30 50.54%
2008 12.15 -27.83%
2007 16.84 25.99%
2006 13.37 -3.87%
2005 13.90 13.98%
2004 12.20 -17.96%
2002 14.87 87.49%
2001 7.93 -26.66%
2000 10.81 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
39.92 -4.34%
US
30.38 -27.21%
FR
- -
JP
41.93 0.47%
US
- -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.